Members in the Media
From: The Telegraph

Anti-epilepsy drug could stave off Alzheimer’s

The Telegraph:

Giving the drug levetiracetam to patients with mild cognitive impairment (MCI), a condition known to foreshadow Alzheimer’s, improved their ability to remember.

It also reduced overactivity in a part of the brain tasked with remembering called the hippocampus, MRI scans showed.

People with MCI who have excess activity in the hippocampus are known to be at the highest risk of being daignosed with full-bolwn Alzheimer’s in the following four to six years.

Read more: The Telegraph

More of our Members in the Media >

APS regularly opens certain online articles for discussion on our website. Effective February 2021, you must be a logged-in APS member to post comments. By posting a comment, you agree to our Community Guidelines and the display of your profile information, including your name and affiliation. Any opinions, findings, conclusions, or recommendations present in article comments are those of the writers and do not necessarily reflect the views of APS or the article’s author. For more information, please see our Community Guidelines.

Please login with your APS account to comment.